angiotensin-receptor blockers
Results Trial description recap V1

Candesartan - Irbesartan - Losartan - Telmisartan - Valsartan

Acute myocardial infarction

all type of patients 3 trials

Diabetes type 2

all type of patients 7 trials

Heart failure

all type of patients 27 trials

patients intolerant to ACE inhibitors 2 trials

patients previously untreated with ACE inhibitors 5 trials

patients already receiving ACE inhibitor 10 trials

patients with preserved-LVEF heart failure 3 trials

Hypertension

all diseases requiring ACEi (HF, CHD, HT,...) 27 trials

Miscellaneous

all type of patients 25 trials

Patients at high risk for cardiovascular events

all type of patients 10 trials

patients intolerant to ACE inhibitors 1 trials